Key Takeaways
- • Blackstone shares declined modestly as the world's largest alternative asset manager faces valuation pressure following recent earnings, with the stock trading near $115.35 as of June 5, 2026, down from 52-week highs of $190.09.
- • Analyst price targets remain divergent, with TD Cowen lowering its target to $133 from $140 (maintaining a Buy rating), while the consensus median target across 67 analysts stands at $161.21, indicating a 40% upside potential at consensus valuations.
- • Private credit and insurance business segments showed weakness despite strong overall earnings performance, with Q4 2025 EPS of $1.75 exceeding consensus by 14.38%, highlighting segment-specific headwinds offsetting broader operational strength.
- • Trading valuation metrics reveal a trailing P/E of 28.28 and forward P/E of 18.35, with the stock trading at a 6.87x price-to-sales multiple, suggesting modest undervaluation relative to historical earnings growth averaging 30% annually over three years versus 7% share price appreciation.
- • Institutional positioning shows mixed sentiment with 1,065 institutional investors adding shares while 887 decreased positions, reflecting uncertainty around private credit exposure and near-term headwinds despite long-term fundamentals remaining robust.
Summary
Blackstone Inc. shares eased following earnings releases, with the alternative asset manager's stock trading near $115.35 as of June 5, 2026, representing a 2.70% decline on the day. The decline occurred despite the company topping earnings and revenue estimates in recent quarters, underscoring investor concerns about valuation and specific business segment weakness rather than systemic operational deterioration.
The stock's recent underperformance since January 2026 reflects divergent views on fair value. TD Cowen reduced its price target to $133 from $140 on May 18, 2026, while maintaining a Buy rating, suggesting modest downside to consensus. However, the broader analyst community remains more optimistic, with 67 analysts covering the stock and a median price target of $161.21—implying approximately 40% upside from current levels. Individual analyst estimates range widely from $118 to $215, reflecting the disparity in how different investors assess Blackstone's growth trajectory and risk profile.
Earnings fundamentals present a mixed picture. The company reported Q4 2025 earnings per share of $1.75, beating consensus expectations of $1.53 by 14.38%. Additionally, Q3 2025 results showed earnings and revenue surprises of 25.62% and 7.62%, respectively. However, investor concerns center on weakness in the private credit and insurance business segments, which have faced headwinds despite strength elsewhere in Blackstone's portfolio. This segment-level weakness has tempered broader enthusiasm despite the company's proven ability to beat earnings estimates.
Valuation metrics present a nuanced investment case. At a trailing P/E of 28.28 and forward P/E of 18.35, Blackstone trades at a meaningful discount to growth, particularly given that earnings per share have grown 30% annually on average over three years while the share price appreciated only 7% over the same period. The trailing price-to-sales ratio of 6.87x appears modest relative to the company's profitability metrics—a net profit margin of 21.21% and return on equity of 29.53%—suggesting the stock may offer value for growth-oriented investors with conviction in private credit recovery.
Institutional sentiment reflects this bifurcated outlook, with 1,065 institutional investors adding shares during recent periods while 887 decreased positions, indicating genuine disagreement about near-term catalysts and valuation support. The forward dividend yield of 4.19% provides modest income support, while the company's $2.61 billion cash position and strong balance sheet provide downside protection. For sophisticated investors, Blackstone presents a contrarian opportunity contingent upon private credit stabilization and a narrowing of analyst valuations toward consensus targets.
The stock's recent underperformance since January 2026 reflects divergent views on fair value. TD Cowen reduced its price target to $133 from $140 on May 18, 2026, while maintaining a Buy rating, suggesting modest downside to consensus. However, the broader analyst community remains more optimistic, with 67 analysts covering the stock and a median price target of $161.21—implying approximately 40% upside from current levels. Individual analyst estimates range widely from $118 to $215, reflecting the disparity in how different investors assess Blackstone's growth trajectory and risk profile.
Earnings fundamentals present a mixed picture. The company reported Q4 2025 earnings per share of $1.75, beating consensus expectations of $1.53 by 14.38%. Additionally, Q3 2025 results showed earnings and revenue surprises of 25.62% and 7.62%, respectively. However, investor concerns center on weakness in the private credit and insurance business segments, which have faced headwinds despite strength elsewhere in Blackstone's portfolio. This segment-level weakness has tempered broader enthusiasm despite the company's proven ability to beat earnings estimates.
Valuation metrics present a nuanced investment case. At a trailing P/E of 28.28 and forward P/E of 18.35, Blackstone trades at a meaningful discount to growth, particularly given that earnings per share have grown 30% annually on average over three years while the share price appreciated only 7% over the same period. The trailing price-to-sales ratio of 6.87x appears modest relative to the company's profitability metrics—a net profit margin of 21.21% and return on equity of 29.53%—suggesting the stock may offer value for growth-oriented investors with conviction in private credit recovery.
Institutional sentiment reflects this bifurcated outlook, with 1,065 institutional investors adding shares during recent periods while 887 decreased positions, indicating genuine disagreement about near-term catalysts and valuation support. The forward dividend yield of 4.19% provides modest income support, while the company's $2.61 billion cash position and strong balance sheet provide downside protection. For sophisticated investors, Blackstone presents a contrarian opportunity contingent upon private credit stabilization and a narrowing of analyst valuations toward consensus targets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.